Patents by Inventor SANOFI PASTEUR INC.

SANOFI PASTEUR INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine
    Publication number: 20130224241
    Abstract: The present invention describes a combined vaccine that offers broad protection against meningococcal disease caused by the pathogenic bacteria Neisseria meningitidis. The vaccine is comprised of four distinct polysaccharide-protein conjugates that are formulated as a single dose of vaccine. Purified capsular polysaccharides from Neisseria meningitidis serogroups A, C, W-135, and Y are chemically activated and selectively attached to a carrier protein by means of a covalent chemical bond, forming polysaccharide-protein conjugates capable of eliciting long-lasting immunity to a variety of N. meningitidis strains in children as well as adults.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 29, 2013
    Inventor: SANOFI PASTEUR INC.
  • Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine
    Publication number: 20130216571
    Abstract: The present invention describes a combined vaccine that offers broad protection against meningococcal disease caused by the pathogenic bacteria Neisseria meningitidis. The vaccine is comprised of four distinct polysaccharide-protein conjugates that are formulated as a single dose of vaccine. Purified capsular polysaccharides from Neisseria meningitidis serogroups A, C, W-135, and Y are chemically activated and selectively attached to a carrier protein by means of a covalent chemical bond, forming polysaccharide-protein conjugates capable of eliciting long-lasting immunity to a variety of N. meningitidis strains in children as well as adults.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 22, 2013
    Inventor: Sanofi Pasteur Inc.
  • Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine
    Publication number: 20130177588
    Abstract: The present invention describes a combined vaccine that offers broad protection against meningococcal disease caused by the pathogenic bacteria Neisseria meningitidis. The vaccine is comprised of four distinct polysaccharide-protein conjugates that are formulated as a single dose of vaccine. Purified capsular polysaccharides from Neisseria meningitidis serogroups A, C, W-135, and Y are chemically activated and selectively attached to a carrier protein by means of a covalent chemical bond, forming polysaccharide-protein conjugates capable of eliciting long-lasting immunity to a variety of N. meningitidis strains in children as well as adults.
    Type: Application
    Filed: January 10, 2013
    Publication date: July 11, 2013
    Applicant: SANOFI PASTEUR INC.
    Inventor: SANOFI PASTEUR INC.